Peak Bio, Inc. announced that it has entered into a forward purchase agreement to issue common shares at a purchase price of $10 per share for the aggregate gross proceeds of $10,000,000 on April 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0096 USD | +11.63% |
|
-.--% | -94.88% |
Jun. 25 | Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
May. 28 | Peak Bio, Inc. announced that it has received $1.3245 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-94.88% | 222K | |
+25.83% | 47.96B | |
+45.66% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Peak Bio, Inc. announced that it expects to receive $10 million in funding